These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 20564593)
21. Comparison of Botox with a Chinese type A botulinum toxin. Tang X; Wan X Chin Med J (Engl); 2000 Sep; 113(9):794-8. PubMed ID: 11776072 [TBL] [Abstract][Full Text] [Related]
22. What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection. Khan S; Kessler TM; Apostolidis A; Kalsi V; Panicker J; Roosen A; Gonzales G; Haslam C; Elneil S; Fowler CJ; Dasgupta P J Urol; 2009 Apr; 181(4):1773-8. PubMed ID: 19233414 [TBL] [Abstract][Full Text] [Related]
23. Prospective randomized evaluation of periureteral botulinum toxin type A injection for ureteral stent pain reduction. Gupta M; Patel T; Xavier K; Maruffo F; Lehman D; Walsh R; Landman J J Urol; 2010 Feb; 183(2):598-602. PubMed ID: 20018320 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials. Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252 [TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study. Gracies JM; Lugassy M; Weisz DJ; Vecchio M; Flanagan S; Simpson DM Arch Phys Med Rehabil; 2009 Jan; 90(1):9-16.e2. PubMed ID: 19154823 [TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin versus submandibular duct relocation for severe drooling. Scheffer AR; Erasmus C; VAN Hulst K; VAN Limbeek J; Rotteveel JJ; Jongerius PH; van den Hoogen FJ Dev Med Child Neurol; 2010 Nov; 52(11):1038-42. PubMed ID: 20561006 [TBL] [Abstract][Full Text] [Related]
27. Spastic cocontraction in hemiparesis: effects of botulinum toxin. Vinti M; Costantino F; Bayle N; Simpson DM; Weisz DJ; Gracies JM Muscle Nerve; 2012 Dec; 46(6):926-31. PubMed ID: 23042034 [TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin A for treatment of allodynia of complex regional pain syndrome: a pilot study. Safarpour D; Salardini A; Richardson D; Jabbari B Pain Med; 2010 Sep; 11(9):1411-4. PubMed ID: 20609130 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and Safety of a New Botulinum Toxin Type A Free of Complexing Proteins. Oh HM; Park JH; Song DH; Chung ME Toxins (Basel); 2015 Dec; 8(1):. PubMed ID: 26712786 [TBL] [Abstract][Full Text] [Related]
30. Single CT-guided chemodenervation of the anterior scalene muscle with botulinum toxin for neurogenic thoracic outlet syndrome. Christo PJ; Christo DK; Carinci AJ; Freischlag JA Pain Med; 2010 Apr; 11(4):504-11. PubMed ID: 20202146 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. Sahai A; Khan MS; Dasgupta P J Urol; 2007 Jun; 177(6):2231-6. PubMed ID: 17509328 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study. Göbel H; Heinze A; Reichel G; Hefter H; Benecke R; Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294 [TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study. Graboski CL; Gray DS; Burnham RS Pain; 2005 Nov; 118(1-2):170-5. PubMed ID: 16202527 [TBL] [Abstract][Full Text] [Related]
34. A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystonia. Quagliato EM; Carelli EF; Viana MA Clin Neuropharmacol; 2010; 33(1):22-6. PubMed ID: 19959960 [TBL] [Abstract][Full Text] [Related]
35. Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment. Quagliato EM; Carelli EF; Viana MA Clin Neuropharmacol; 2010; 33(1):27-31. PubMed ID: 20124784 [TBL] [Abstract][Full Text] [Related]
36. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy. Crowner BE; Racette BA Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363 [TBL] [Abstract][Full Text] [Related]
37. Dose- and volume dependent-response to intramuscular injection of botulinum neurotoxin-A optimizes muscle force decrement in mice. Stone AV; Ma J; Callahan MF; Smith BP; Garrett JP; Smith TL; Koman LA J Orthop Res; 2011 Nov; 29(11):1764-70. PubMed ID: 21491479 [TBL] [Abstract][Full Text] [Related]
38. Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder. Haferkamp A; Schurch B; Reitz A; Krengel U; Grosse J; Kramer G; Schumacher S; Bastian PJ; Büttner R; Müller SC; Stöhrer M Eur Urol; 2004 Dec; 46(6):784-91. PubMed ID: 15548448 [TBL] [Abstract][Full Text] [Related]
39. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases. Baş B; Ozan B; Muğlali M; Celebi N Med Oral Patol Oral Cir Bucal; 2010 Jul; 15(4):e649-52. PubMed ID: 20173718 [TBL] [Abstract][Full Text] [Related]